BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25971546)

  • 1. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
    Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T
    Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
    El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA
    Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma.
    Lim D; Ip PP; Cheung AN; Kiyokawa T; Oliva E
    Am J Surg Pathol; 2015 Aug; 39(8):1061-9. PubMed ID: 25871622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
    APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
    Ramos-Vara JA; Frank CB; DuSold D; Miller MA
    J Comp Pathol; 2016 Nov; 155(4):286-298. PubMed ID: 27567273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
    Chernock RD; El-Mofty SK; Becker N; Lewis JS
    Am J Surg Pathol; 2013 Aug; 37(8):1215-22. PubMed ID: 23681073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
    Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
    Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
    Fadare O; Desouki MM; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Parkash V; Hecht JL
    Am J Surg Pathol; 2014 Feb; 38(2):189-96. PubMed ID: 24145649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma.
    Li Q; Zeng X; Cheng X; Zhang J; Ji J; Wang J; Xiong K; Qi Q; Huang W
    Int J Clin Exp Pathol; 2015; 8(7):8305-10. PubMed ID: 26339401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Napsin-A, a Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas.
    Alshenawy HA; Radi DA
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):605-610. PubMed ID: 28362708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
    Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.
    Lu L; Wang S; Zhu Q; Qu Y; Gu W; Ning Y; Chen X; Wang Y
    Pathol Res Pract; 2018 Aug; 214(8):1087-1094. PubMed ID: 29866423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas.
    Nili F; Tavakoli M; Izadi Mood N; Saffar H; Sarmadi S
    Iran J Pathol; 2020; 15(2):81-85. PubMed ID: 32215023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
    Nonaka D; Chiriboga L; Soslow RA
    Am J Surg Pathol; 2008 Oct; 32(10):1566-71. PubMed ID: 18724243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.
    Kim MY; Go H; Koh J; Lee K; Min HS; Kim MA; Jeon YK; Lee HS; Moon KC; Park SY; Kim WH; Chung DH
    Histopathology; 2014 Aug; 65(2):195-206. PubMed ID: 24479710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].
    Wang J; Li Q; Cheng X; Xiong K; Qi Q; Huang W
    Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):874-8. PubMed ID: 26888504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.
    Terra SB; Aubry MC; Yi ES; Boland JM
    Hum Pathol; 2014 Feb; 45(2):294-302. PubMed ID: 24331839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA; Sharma R; Illei PB
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.